STOCK TITAN

Capital Bancorp SEC Filings

CBNK Nasdaq

Welcome to our dedicated page for Capital Bancorp SEC filings (Ticker: CBNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Capital Bancorp, Inc. (NASDAQ: CBNK) SEC filings page on Stock Titan provides access to the company’s official U.S. Securities and Exchange Commission disclosures, along with AI-powered summaries to help interpret complex documents. As a publicly traded bank holding company for Capital Bank, N.A., Capital Bancorp files periodic reports, current reports, and other regulatory documents that describe its financial condition, risk profile, capital structure, and governance.

Investors can review Form 10-K annual reports for a comprehensive discussion of business segments such as commercial banking, mortgage banking, credit cards, government loan servicing, and corporate activities, as well as risk factors and management’s analysis. Form 10-Q quarterly reports provide interim updates on net interest income, fee revenue, loan and deposit growth, allowance for credit losses, and the impact of transactions like the Integrated Financial Holdings, Inc. acquisition.

Form 8-K current reports are particularly relevant for CBNK, documenting material events such as quarterly earnings releases, cash dividend declarations, changes in executive officers, board appointments, and planned redemptions of subordinated notes. These filings give timely insight into management decisions, capital actions, and leadership changes.

Users can also access proxy statements for information on board structure, director independence, and compensation of non-employee directors, as referenced in the company’s description of its governance practices. Where applicable, Form 4 insider trading reports reveal transactions by directors and executive officers in CBNK shares.

Stock Titan’s interface surfaces new filings in near real time from EDGAR and applies AI-generated highlights so readers can quickly identify key points—such as changes in dividend policy, credit quality metrics, or capital instruments—without reading every page. This makes it easier to analyze Capital Bancorp’s regulatory history and ongoing disclosure record.

Rhea-AI Summary

Capital Bancorp Inc (CBNK) director Mark M. Caplan reported his beneficial ownership of company securities as of an event dated 11/21/2025. He directly holds 138,690 shares of common stock. He also reports indirect ownership of 15,000 shares through Mark M. Caplan & Linda W. Caplan U/T, 45,000 shares through a Roth IRA, and 30,000 shares through an investment management account. In addition, he holds stock options covering 1,500, 1,800, 2,265, 2,800, and 3,000 shares at exercise prices between $13.89 and $30.51, plus 811 restricted stock units that are scheduled to vest on 3/3/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Capital Bancorp, Inc. appointed Mark Caplan as a Class II director on its Board of Directors, effective November 21, 2025, increasing the Board size to thirteen members. As a Class II director, he will be up for re-election at the 2028 annual meeting of stockholders.

Mr. Caplan has served on the board of Capital Bank, N.A. since January 2019 and sits on its Loan Committee. He is President and Chief Executive Officer of The Time Group, a real estate equity investment firm, and the managing member and sole shareholder of Washington Place Equities, a development firm focused on mixed-use urban historic projects. He has prior bank board experience at Sterling Bank and Trust and Bay Bank, FSB.

The Board determined that Mr. Caplan is an independent director under SEC and Nasdaq rules. He was also appointed to the Board’s Compensation Committee and Risk Committee and will receive the Company’s standard non-employee director compensation. The Company states there are no related-party transactions or special arrangements connected to his selection as director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Capital Bancorp Inc. (CBNK)3,000 shares of common stock at $13.89 per share, increasing his direct holdings to 5,505 shares immediately after the exercise. He then disposed of 2,282 shares in a transaction coded "F" at $26.66 per share, typically used for shares withheld or sold to cover taxes, leaving 3,223 directly held shares. Subsequent transactions coded "G" reflect gifts, including transfers of 965 shares from direct ownership and additions to Uniform Transfers to Minors Act (UTMA) accounts for four grandchildren, resulting in 2,258 directly held shares and several indirect positions. Brannan continues to hold multiple stock option grants and 946 restricted stock units that are scheduled to vest on 3/3/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Capital Bancorp Inc. (CBNK)11/18/2025. He exercised stock options to acquire 3,750 shares of common stock at an exercise price of $13.89 per share (transaction code M). After this transaction, he beneficially owns 31,310 common shares directly and 16,672 shares indirectly through Dominion Insurance Inc.

Lewis continues to hold multiple stock option grants with exercise prices ranging from $23.54 to $30.51 and expiration dates between 12/31/2026 and 03/03/2030. He also holds 1,081 Restricted Stock Units, each representing one share of common stock, which are scheduled to vest on 03/03/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Capital Bancorp Inc. (CBNK)

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Capital Bancorp (CBNK) insider filing reports that the former EVP and CFO sold 3,400 shares of common stock at $27.95 on 11/12/2025.

Following the sale, the reporting person beneficially owned 1,434 shares directly. He also holds 500 stock options with a $21.57 exercise price, exercisable on 07/15/2025 and expiring on 07/15/2029. A footnote states that of an original 2,000 options, 1,500 were forfeited upon resignation on 10/27/2025, leaving 500 vested.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Capital Bancorp (CBNK) reported an insider transaction by a director and officer (Pres, Specialty & CRE Lending). On 11/07/2025, the insider exercised stock options for 8,500 shares of common stock at $13.89 per share (code M) and disposed of 4,669 shares at $27.94 (code F).

Following these transactions, the insider directly beneficially owned 517,418 shares. The filing also lists remaining derivative holdings, including multiple stock option grants with stated exercise prices and vesting schedules, and 825 RSUs scheduled to vest in installments beginning 3/3/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Capital Bancorp (CBNK) reported stronger Q3 2025 results. Net income was $15.1 million with diluted EPS of $0.89, up from $0.62 a year ago. Net interest income rose to $52.0 million from $38.4 million as higher loan yields drove revenue, while total noninterest income increased to $11.1 million from $6.6 million.

Total assets reached $3.39 billion. Portfolio loans were $2.83 billion versus $2.64 billion at year-end 2024, and deposits were $2.91 billion versus $2.76 billion. The allowance for credit losses was $53.0 million. Stockholders’ equity rose to $394.8 million, aided by improved accumulated other comprehensive loss of $(6.8) million.

The IFH acquisition accounting was finalized, increasing goodwill by $4.8 million to $26.0 million, with $0.7 million of merger-related expenses in Q3. Credit metrics were mixed: nonaccrual loans were $52.2 million at September 30, 2025 compared with $30.2 million at December 31, 2024. As of November 6, 2025, 16,520,863 common shares were outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Capital Bancorp Inc. (CBNK) reported an initial insider ownership statement for its SVP & CAO, signed by Connie Egan. The reporting person directly holds 3,884.7802 shares of common stock. Derivative holdings include stock options for 2,000 shares at $13.89 expiring 12/31/2025, 1,050 at $26.41 expiring 12/31/2026, 1,600 at $23.54 expiring 01/01/2028, 2,000 at $24.20 expiring 01/01/2029, and 1,339 at $30.51 expiring 03/03/2030. The filing also lists 361 restricted stock units that vest in four equal annual installments beginning on 3/3/26. The options vest in four equal annual installments beginning on the first anniversary of each grant.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Capital Bancorp, Inc. (CBNK) announced it will redeem all outstanding 5.00% Fixed-to-Floating Rate Subordinated Notes due 2030 on November 30, 2025. The outstanding balance is $10,000,000, and the redemption price will be 100% of principal plus accrued and unpaid interest to, but excluding, the redemption date.

This action retires debt five years ahead of the original maturity. The redemption removes interest obligations on these notes after November 30, 2025 and represents a cash outflow equal to principal plus accrued interest at settlement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Capital Bancorp (CBNK)?

The current stock price of Capital Bancorp (CBNK) is $31.4 as of February 12, 2026.

What is the market cap of Capital Bancorp (CBNK)?

The market cap of Capital Bancorp (CBNK) is approximately 515.7M.
Capital Bancorp

Nasdaq:CBNK

CBNK Rankings

CBNK Stock Data

515.68M
11.12M
30.27%
42.17%
2.35%
Banks - Regional
National Commercial Banks
Link
United States
Rockville

CBNK RSS Feed